Targeting of BRM sensitizes BRG1-mutant lung cancer cell lines to radiotherapy.
2019-03-25

2019. Zernickel E, Sak A, Riaz A, Klein D, Groneberg M, Stuschke M. Molecular Cancer Therapeutics 18(3): 656-666.